Skip to content

To evaluate the therapeutic effectiveness of nasiyam using Aathondai nasiya thylam in the management of Peenisam (Sinusitis)

An open labelled non randomized phase II clinical trial to evaluate the therapeutic effectiveness of nasiyam(An external therapy)using -Aathondai nasiya thylam in the management of Peenisam - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085801
Enrollment
40
Registered
2025-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J329- Chronic sinusitis, unspecified

Interventions

Intervention1: Aathondai nasiya thylam: Nasal drops for 21 days Control Intervention1: Nil: Nil

Sponsors

Dr R MEENA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from symptoms like nasal congestion, continuous sneezing ,headache or heaviness of head,pain in the face and ear,nasal or postnasal discharge, hyposmia Patients who are willing to give radiological investigation and provide blood for lab investigation Patients who are willing to sign the informed consent stating that he/she will stick to the treatment during the study period but can option out of the trail on his/her own conscious discretion

Exclusion criteria

Exclusion criteria: Age below 15 years and above 70 years Patients suffering from epistaxis, lower respiratory tract infections, CAD, Tuberculosis,HIV,Cancer pregnant and lactating women, Epilepsy,CSF Rhinorrhoea, Haemophilia

Design outcomes

Primary

MeasureTime frame
Patients symptoms will be reduced along with their improvement in their quality of lifeTimepoint: 21 days

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDrSSUJATHA MDs

Government Siddha Medical College and Hospital

ganesangabriel@gmail.com9842474166

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026